NIAID is always steadily adjusting its strategic priorities in response to new research findings and emerging threats to public health. Any recent changes to our priorities would be a product of the Institute’s usual practices, rather than a consequence of former NIAID Director Dr. Anthony Fauci’s departure. The Institute strives to maintain a well-balanced scientific portfolio in fulfillment of the NIAID Mission.
Moreover, each individual funding initiative undergoes a deliberate, collaborative vetting process that includes oversight by NIAID’s Advisory Council. Learn more at Understand NIAID Research Priorities.